Medicine Supply Notification: Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solution – Updated
15/02/2022: Resupply now expected to be May 2022
Department of Health and Social Care (DHSC) has issued a medicine supply notification for Locorten Vioform®
(flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops solution
MSN/2021/036
Tier 2 – medium impact
Date of issue 21st July 2021
- Locorten Vioform® (flumetasone/clioquinol) 0.02% w/v / 1% w/v ear drops are out of stock until April 2022.
- There are no other combination products on market that contain a steroid and an antimicrobial agent with both antibacterial and antifungal properties
- Alternative topical combination steroid and antibacterial preparations for the ear are available
- The only topical antifungal preparation on the market for use in the ear is Canesten® (clotrimazole) 1% solution
A copy of this medicine supply notification has been sent to all pharmacy NHS email addresses.
The DHSC Medicine Supply Team provide a monthly update on potential supply issues affecting both primary and secondary care. This update is uploaded on the Specialist Pharmacy Services (SPS) website. To register, you will need an NHS email address. Once set up and logged in, you will be able to access it online.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
